#Latest news with #eye diseaseBloomberg24-07-2025BusinessBloombergRoche First-Half Earnings Beat Estimates on Asthma, Eye DrugsRoche Holding AG said first-half profit advanced, helped by sales of medicines for asthma, eye disease and multiple sclerosis. Earnings per share excluding some items climbed 8% to 11.08 Swiss francs ($13.98), the drugmaker said Thursday. That beat the average estimate of analysts surveyed by Bloomberg.
Bloomberg24-07-2025BusinessBloombergRoche First-Half Earnings Beat Estimates on Asthma, Eye DrugsRoche Holding AG said first-half profit advanced, helped by sales of medicines for asthma, eye disease and multiple sclerosis. Earnings per share excluding some items climbed 8% to 11.08 Swiss francs ($13.98), the drugmaker said Thursday. That beat the average estimate of analysts surveyed by Bloomberg.
24-07-2025
